U.S. GoldMining loses Nasdaq audit-committee compliance; cure period granted
Nasdaq notified U.S. GoldMining it no longer meets audit committee requirements under Nasdaq Listing Rule 5605 after a director’s resignation. The cure period runs until the earlier of the next annual meeting or August 14, 2027.
On August 27, 2026, the company received notice from Nasdaq that, following a director's resignation, it no longer meets the audit committee requirements under Nasdaq Listing Rule 5605.
Nasdaq granted a cure period until the earlier of the next annual meeting or August 14, 2027 (or, if the meeting…